Diabetic ketoacidosis, neuroleptic malignant syndrome, and myocardial infarction in a patient taking risperidone and lithium carbonate.
Ananth
Jambur
J
Johnson
Karen M
KM
Levander
Eric M
EM
Harry
Jonathan L
JL
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced / Q000175:diagnosis; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology*; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D018967:Risperidone